GROWTH OPPORTUNITIES IN CELL AND GENE THERAPIES, RETINAL DISEASES, DRUG DELIVERY PLATFORMS, PLANT-BASED DRUGS, CARDIAC HEALTH, AI-BASED DEVICES, COMPUTATION METHODS, AND CULTURED MILK

GROWTH OPPORTUNITIES IN CELL AND GENE THERAPIES, RETINAL DISEASES, DRUG DELIVERY PLATFORMS, PLANT-BASED DRUGS, CARDIAC HEALTH, AI-BASED DEVICES, COMPUTATION METHODS, AND CULTURED MILK

RELEASE DATE
19-Mar-2021
REGION
Global
Research Code: D759-00-1E-00-00
SKU: HC03399-GL-TA_25312
$950.00
In stock
SKU
HC03399-GL-TA_25312
$950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across retinal diseases, viral and non-viral vector platforms for gene therapies, allogeneic cell therapy, bone repair, gluten antigen-specific drug therapy for Celiac disease, plant-based anti-cancer agents, and food colors. Further, PCR-free whole genome sequencing, oral protein-drug delivery technology for insulin, and cryo transmission electron microscope for viral protein analysis are discussed.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Diabetic macular oedema, presbyopia, bone fractures, skeletal fragility, Celiac disease, Celiac sprue, gluten-sensitive enteropathy, artificial intelligence, gene therapy, non-viral vectors, CRISPR gene therapy, adeno-associated virus (AAV) capsid engineering, anti-cancer green tea derivative, plant-based meat, natural colorants, protein oral delivery, diabetes, dry eye syndrome, Sjögren’s syndrome, hypoplastic left heart syndrome, automated cryo transmission electron microscope, oral insulin, whole genome sequencing, AI rapid oral drug delivery, Medicinal cell signaling (MCS), regenerative therapy, artificial tear, Lomecel-B, allogeneic cell therapy

Table of Contents

INNOVATIONS IN LIFE SCIENCES, HEALTH & WELLNESS

  • EXONATE LTD., UK
  • VISUS THERAPEUTICS INC., WA,US
  • NOVOSTEO INC., CA,US
  • ANOKION SA, SWITZERLAND
  • DYNO THERAPEUTICS, US
  • SPOTLIGHT THERAPEUTICS, US
  • RENSSELAER POLYTECHNIC INSTITUTE, US
  • NATUREX SA, FRANCE
  • ORAMED PHARMACEUTICALS, NY, US
  • WIZE PHARMA, ISRAEL
  • LONGEVERON, FL, US
  • THERMO FISHER SCIENTIFIC, MA, US
  • VARIANTYX, US
  • RAPID DOSE THERAPEUTICS, CANADA

KEY CONTACTS

  • KEY CONTACTS
  • KEY CONTACTS
  • KEY CONTACTS
  • KEY CONTACTS
  • Legal Disclaimer
Related Research
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across retinal diseases, viral and non-viral vector platforms for gene therapies, allogeneic cell therapy, bone repair, gluten antigen-specific drug therapy for Celiac disease, plant-based anti-cancer agents, and food colors. Further, PCR-free whole genome sequencing, oral protein-drug delivery technology for insulin, and cryo transmission electron microscope for viral protein analysis are discussed. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Diabetic macular oedema, presbyopia, bone fractures, skeletal fragility, Celiac disease, Celiac sprue, gluten-sensitive enteropathy, artificial intelligence, gene therapy, non-viral vectors, CRISPR gene therapy, adeno-associated virus (AAV) capsid engineering, anti-cancer green tea derivative, plant-based meat, natural colorants, protein oral delivery, diabetes, dry eye syndrome, Sjögrens syndrome, hypoplastic left heart syndrome, automated cryo transmission electron microscope, oral insulin, whole genome sequencing, AI rapid oral drug delivery, Medicinal cell signaling (MCS), regenerative therapy, artificial tear, Lomecel-B, allogeneic cell therapy
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number D759-00-1E-00-00
Is Prebook No
Ti Codes D759